Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Payables (2024 - 2025)

Allarity Therapeutics' Payables history spans 2 years, with the latest figure at $5.7 million for Q4 2025.

  • For Q4 2025, Payables rose 2.71% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, up 2.71%, while the annual FY2025 figure was $5.7 million, 2.71% up from the prior year.
  • Payables reached $5.7 million in Q4 2025 per ALLR's latest filing, down from $6.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $13.7 million in Q1 2024 to a low of $5.5 million in Q4 2024.